Raised serum amylase in patients with COVID-19 may not be associated with pancreatitis
Jonny Stephens, Joyce Wong, R. Broomhead, Richard Stümpfle, U. Waheed, P. Patel, Stephen J. Brett, Sanooj Soni
Abstract
A high incidence of pancreatitis in COVID-19 has been reported. Although a high proportion of critically unwell patients with COVID-19 have raised serum amylase levels, this does not necessarily reflect acute pancreatitis or a clinically important pancreatic injury.
Topics & Concepts
MedicinePancreatitisCoronavirus disease 2019 (COVID-19)Acute pancreatitisIncidence (geometry)GastroenterologyAmylaseInternal medicine2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Intensive care medicinePathologyEnzymeDiseaseBiochemistryChemistryOpticsOutbreakInfectious disease (medical specialty)PhysicsPancreatitis Pathology and TreatmentCOVID-19 Clinical Research StudiesCOVID-19 Impact on Reproduction